SaTH Pharmacy Improving Amendment Implementation (2023)

Type of publication:Service improvement case study

Author(s):*Angela Yeomans

Citation:SaTH Improvement Hub, 2023

Abstract:To improve the process for reviewing and implementing amendments within pharmacy supported research projects by September 2023 as evidenced by percentage performance and adherence to sponsor agreed timelines.

Link to PDF poster

The Transfer of Care Process (2023)

Type of publication:Service improvement case study

Author(s):*Mandy Taylor

Citation:SaTH Improvement Hub, 2023

Abstract:To improve the discharge process for patients where they have identified complex needs by the end of October 2023 as evidenced by a timelier referral to Therapy and IDT teams and decrease in Length of Stay.

Link to PDF Poster

Hypoglycaemia in adrenal insufficiency (2023)

Type of publication:Journal article

Author(s):*Lee, Shien Chen; Baranowski, Elizabeth S; *Sakremath, Rajesh; Saraff, Vrinda; Mohamed, Zainaba

Citation:Frontiers in Endocrinology. 2023. [epub ahead of print]

Abstract:Adrenal insufficiency encompasses a group of congenital and acquired disorders that lead to inadequate steroid production by the adrenal glands, mainly glucocorticoids, mineralocorticoids and androgens. These may be associated with other hormone deficiencies. Adrenal insufficiency may be primary, affecting the adrenal gland's ability to produce cortisol directly; secondary, affecting the pituitary gland's ability to produce adrenocorticotrophic hormone (ACTH); or tertiary, affecting corticotrophin-releasing hormone (CRH) production at the level of the hypothalamus. Congenital causes of adrenal insufficiency include the subtypes of Congenital Adrenal Hyperplasia, Adrenal Hypoplasia, genetic causes of Isolated ACTH deficiency or Combined Pituitary Hormone Deficiencies, usually caused by mutations in essential transcription factors. The most commonly inherited primary cause of adrenal insufficiency is Congenital Adrenal Hyperplasia due to 21-hydroxylase deficiency; with the classical form affecting 1 in 10,000 to 15,000 cases per year. Acquired causes of adrenal insufficiency can be subtyped into autoimmune (Addison's Disease), traumatic (including haemorrhage or infarction), infective (e.g. Tuberculosis), infiltrative (e.g. neuroblastoma) and iatrogenic. Iatrogenic acquired causes include the use of prolonged exogenous steroids and post-surgical causes, such as the excision of a hypothalamic-pituitary tumour or adrenalectomy. Clinical features of adrenal insufficiency vary with age and with aetiology. They are often non-specific and may sometimes become apparent only in times of illness. Features range from those related to hypoglycaemia such as drowsiness, collapse, jitteriness, hypothermia and seizures. Features may also include signs of hypotension such as significant electrolyte imbalances and shock. Recognition of hypoglycaemia as a symptom of adrenal insufficiency is important to prevent treatable causes of sudden deaths. Cortisol has a key role in glucose homeostasis, particularly in the counter-regulatory mechanisms to prevent hypoglycaemia in times of biological stress. Affected neonates particularly appear susceptible to the compromise of these counter-regulatory mechanisms but it is recognised that affected older children and adults remain at risk of hypoglycaemia. In this review, we summarise the pathogenesis of hypoglycaemia in the context of adrenal insufficiency. We further explore the clinical features of hypoglycaemia based on different age groups and the burden of the disease, focusing on hypoglycaemic-related events in the various aetiologies of adrenal insufficiency. Finally, we sum up strategies from published literature for improved recognition and early prevention of hypoglycaemia in adrenal insufficiency, such as the use of continuous glucose monitoring or modifying glucocorticoid replacement.

Link to full-text [open access - no password required]

Acute Floor Review 2023 (2023)

Type of publication:Service improvement case study

Author(s):*Hannah Pope *Rebecca Houlston *Dr Aruna Maharaj *Madeleine Oliver

Citation:SaTH Improvement Hub, July 2023

Abstract:The introduction of the acute medical floor (AMF) will enable ward 22 short stay to achieve a length of stay of 3 days (4320 minutes) by 31st July 2023.

Link to PDF poster

Acute Floor Review 2023: Impact on Ambulance Delays RSH (2023)

Type of publication:Service improvement case study

Author(s):*Hannah Pope *Rebecca Houlston *Dr Aruna Maharaj *Madeleine Oliver

Citation:SaTH Improvement Hub, August 2023

Abstract:The Acute Medical Floor (AMF) will reduce ambulance handover delays <60 mins at RSH by 35% by 31st July 2023.

Link to PDF poster

Acute Floor Review 2023: Impact on time for medical DTA to transfer from the ED (2023)

Type of publication:Service improvement case study

Author(s):*Hannah Pope *Rebecca Houlston *Dr Aruna Maharaj *Madeleine Oliver

Citation:SaTH Improvement Hub, July 2023

Abstract:The Acute Medical Floor (AMF) will reduce time for medical DTA to transfer from the ED by 31st July 2023

Link to PDF poster

Acute Floor Review 2023: Length of stay across the acute floor (2023)

Type of publication:Service improvement case study

Author(s):*Hannah Pope *Rebecca Houlston *Dr Aruna Maharaj *Madeleine Oliver

Citation:SaTH Improvement Hub, July 2023

Abstract:The acute medical floor AMF will achieve expected LOS in AMA (12 hours) & AMU (24 hours) stay by 31st July 2023.

Link to PDF poster

3 of 3 discharge lounge case study for Discharge management tool (2023)

Type of publication:Service improvement case study

Author(s):*Madeleine Oliver

Citation:SaTH Improvement Hub, July 2023

Abstract:To increase the number of patients transferred to the discharge lounge and to increase the number of patients to 10 by 10am by 30th June. The target for the discharge lounge is 30 a day on both sites by 30th September, but for the purpose of this case study we wish to see consistent improvement.

Link to PDF poster